BCM
IONS icon

Barometer Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Barometer Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-17,535
Closed -$1.12M – 174
2015
Q1 		$1.12M Buy
+17,535
New +$1.19M 0.09% 98

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Barometer Capital Management's IONS Position: Q2 2015 in Review

Barometer Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2015, closing a stake of 17,535 shares — an estimated $1.12M sold.

Barometer Capital Management first reported a position in IONS in Q1 2015 and held it in 1 quarter. The position peaked at $1.12M in Q1 2015. 353 funds tracked by Wall St. Rank hold IONS as of Q2 2015.

  • Barometer Capital Management reported no remaining Ionis Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Barometer Capital Management sold 17,535 Ionis Pharmaceuticals shares in Q2 2015, an estimated $1.12M.
  • Barometer Capital Management first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 1 quarter.
  • Barometer Capital Management's Ionis Pharmaceuticals position peaked at $1.12M in Q1 2015.
  • 353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2015.

Based on Barometer Capital Management's 13F filing for Q2 2015, filed 22 Jul 2015.